Header

UZH-Logo

Maintenance Infos

Comment on: F.M. Scherer, "How US antitrust can go astray: the brand name prescription drug litigation"


Zweifel, Peter (1997). Comment on: F.M. Scherer, "How US antitrust can go astray: the brand name prescription drug litigation". International Journal of the Economics of Business, 4(3):277-279.

Abstract

Comments on the article `How US Antirust Can Go Astray: The Brand Name Prescription Drug Litigation,' by F.M. Scherer. Discussion of the issue of patent protection; Uniform monopoly price; Summary of price differentiation between groups of consumers.

Abstract

Comments on the article `How US Antirust Can Go Astray: The Brand Name Prescription Drug Litigation,' by F.M. Scherer. Discussion of the issue of patent protection; Uniform monopoly price; Summary of price differentiation between groups of consumers.

Statistics

Altmetrics

Downloads

1 download since deposited on 11 Feb 2008
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:03 Faculty of Economics > Department of Economics
Dewey Decimal Classification:330 Economics
Uncontrolled Keywords:Antitrust policy; Price discrimination; Patent protection; Pharmaceutical industry
Language:English
Date:1997
Deposited On:11 Feb 2008 12:21
Last Modified:06 Dec 2017 13:11
Publisher:Taylor & Francis
ISSN:1357-1516
Publisher DOI:https://doi.org/10.1080/13571519884530
Related URLs:http://search.ebscohost.com/login.aspx?direct=true&db=buh&AN=9711264790&loginpage=Login.asp&site=ehost-live

Download